ISSN: 1837-9664Journal of Cancer
Global reach, higher impact
J Cancer 2018; 9(8):1430-1436. doi:10.7150/jca.21281 This issue Cite
Research Report
Survivorship and Advocacy in Inflammatory Breast Cancer
1. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston TX
2. Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston TX,
3. The IBC Network Foundation
4. Rice 360 Program, Rice University, Houston TX
5. Metastatic Breast Cancer Network
6. The IBC Network UK
7. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston TX
8. Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston TX
9. Integrative Medicine Program, The University of Texas MD Anderson Cancer Center, Houston TX
Citation:
Alexander A, Arnold TL, Bishnoi S, Ballinger C, Shaitelman SF, Schaverien MV, Cohen L, Dev M, Ueno NT. Survivorship and Advocacy in Inflammatory Breast Cancer. J Cancer 2018; 9(8):1430-1436. doi:10.7150/jca.21281. https://www.jcancer.org/v09p1430.htm
Other stylesAbstract
In February 2017, the Morgan Welch Inflammatory Breast Cancer (IBC) Research Program and Clinic hosted a scientific conference in Houston to commemorate the tenth anniversary of the opening of the first IBC-dedicated clinic in the world. Attendees included basic science researchers, clinicians who treat IBC, as well as patients and their caregivers. Several US-based and international IBC-focused nonprofit organizations were also represented. In this third paper from the conference, we report on the breakout session regarding survivorship and advocacy issues related to IBC, sharing an overview of the educational content presented and discussions regarding the future of IBC advocacy. Panelists focused on lymphedema research and clinical solutions, integrative medicine, and social work, with time provided for questions in small groups. IBC nonprofits that are leading advocacy efforts were introduced, and ways to become involved in these initiatives were discussed. Priorities for future advocacy and clinical care needs were also highlighted. In addition to summarizing these topics, we provide a suggested integrated IBC-specific plan of care that could be provided to the patient at the beginning of care and referred to throughout treatment and follow-up.
Keywords: Inflammatory breast cancer, Advocacy, Survivorship needs, Patients, Lymphedema, Follow-up
Citation styles
APA
Alexander, A., Arnold, T.L., Bishnoi, S., Ballinger, C., Shaitelman, S.F., Schaverien, M.V., Cohen, L., Dev, M., Ueno, N.T. (2018). Survivorship and Advocacy in Inflammatory Breast Cancer. Journal of Cancer, 9(8), 1430-1436. https://doi.org/10.7150/jca.21281.
ACS
Alexander, A.; Arnold, T.L.; Bishnoi, S.; Ballinger, C.; Shaitelman, S.F.; Schaverien, M.V.; Cohen, L.; Dev, M.; Ueno, N.T. Survivorship and Advocacy in Inflammatory Breast Cancer. J. Cancer 2018, 9 (8), 1430-1436. DOI: 10.7150/jca.21281.
NLM
Alexander A, Arnold TL, Bishnoi S, Ballinger C, Shaitelman SF, Schaverien MV, Cohen L, Dev M, Ueno NT. Survivorship and Advocacy in Inflammatory Breast Cancer. J Cancer 2018; 9(8):1430-1436. doi:10.7150/jca.21281. https://www.jcancer.org/v09p1430.htm
CSE
Alexander A, Arnold TL, Bishnoi S, Ballinger C, Shaitelman SF, Schaverien MV, Cohen L, Dev M, Ueno NT. 2018. Survivorship and Advocacy in Inflammatory Breast Cancer. J Cancer. 9(8):1430-1436.
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.